Avadel Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

Rhea-AI Summary

DUBLIN, Ireland, May 25, 2021 – Avadel Pharmaceuticals (Nasdaq: AVDL) announced that CEO Greg Divis will participate in a fireside chat on June 1 at 9:00 a.m. ET. This event will focus on FT218, an investigational once-nightly formulation of sodium oxybate aimed at treating excessive daytime sleepiness and cataplexy in adults with narcolepsy. A live webcast and an archived recording will be accessible on Avadel’s Investor Relations website for 90 days following the conference.

DUBLIN, Ireland, May 25, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for treating excessive daytime sleepiness and cataplexy in adults with narcolepsy, announced today that Greg Divis, Chief Executive Officer of Avadel, will participate in a fireside chat on Tuesday, June 1 at 9:00 a.m. ET.

A live webcast of this event, as well as an archived recording, will be available on Avadel’s Investor Relations website, www.investors.avadel.com, for 90 days following the conference.

About Avadel Pharmaceuticals plc
Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company primarily focused on the development and FDA approval of FT218, an investigational, once-nightly, extended-release formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy. For more information, please visit www.avadel.com.

Investor Contact:
Courtney Turiano
Stern Investor Relations, Inc.
Courtney.Turiano@sternir.com
(212) 698-8687

Media Contact:
Nicole Raisch Goelz
Real Chemistry
ngoelz@realchemistry.com
(408) 568-4292

FAQ

What is the date and time of the Avadel Pharmaceuticals fireside chat?

The fireside chat will take place on June 1, 2021, at 9:00 a.m. ET.

Who will represent Avadel Pharmaceuticals during the fireside chat?

Greg Divis, the Chief Executive Officer of Avadel Pharmaceuticals, will participate.

What is FT218, and what condition does it aim to treat?

FT218 is an investigational, once-nightly formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy.

Where can I watch the Avadel Pharmaceuticals fireside chat?

The fireside chat can be watched live and later archived on Avadel’s Investor Relations website.

How long will the archived recording of the fireside chat be available?

The archived recording will be available for 90 days following the conference.